NexImmune (NEXI) Short Interest Ratio & Short Volume

Short interest is the volume of NexImmune shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 17,800 shares of NEXI short. 2.26% of NexImmune's shares are currently sold short. Learn More on NexImmune's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.26% of NexImmune's floating shares are currently sold short.

NexImmune saw a decrease in short interest in March. As of March 31st, there was short interest totaling 17,800 shares, a decrease of 49.4% from the previous total of 35,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

NexImmune currently has issued a total of 1,370,000 shares. Some of NexImmune's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NexImmune currently has a public float of 788,800 shares.

2.26% of NexImmune's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NexImmune: Mustang Bio, Inc. (2.35%), GeoVax Labs, Inc. (0.31%), Evoke Pharma, Inc. (0.78%), Cingulate Inc. (1.21%), Virpax Pharmaceuticals, Inc. (3.42%), Biophytis S.A. (0.73%), Kintara Therapeutics, Inc. (1.69%), Tharimmune, Inc. (0.65%), Atreca, Inc. (0.37%), 60 Degrees Pharmaceuticals, Inc. (0.75%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling NEXI is an investing strategy that aims to generate trading profit from NexImmune as its price is falling. NEXI shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for NexImmune occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NEXI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NEXI, twice per month. The most recent reporting period available is March, 31 2024.